Detalhe da pesquisa
1.
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
BJU Int
; 119(2): 216-224, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27409523
2.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Lancet
; 384(9959): 2027-35, 2014 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25108889
3.
Prostate-cancer mortality at 11 years of follow-up.
N Engl J Med
; 366(11): 981-90, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22417251
4.
Quality-of-life effects of prostate-specific antigen screening.
N Engl J Med
; 367(7): 595-605, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22894572
5.
Do Treatment Differences between Arms Affect the Main Outcome of ERSPC Rotterdam?
J Urol
; 194(2): 336-42, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698407
6.
A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
Psychooncology
; 24(3): 348-54, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25138075
7.
Prevention and early detection of prostate cancer.
Lancet Oncol
; 15(11): e484-92, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25281467
8.
Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
Prostate
; 74(5): 488-96, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375374
9.
Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial.
World J Urol
; 32(5): 1287-94, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24258313
10.
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
World J Urol
; 32(1): 185-91, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22527674
11.
Screening for prostate cancer: current status of ERSPC and screening-related issues.
Recent Results Cancer Res
; 202: 47-51, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24531776
12.
ERSPC, PLCO studies and critique of cochrane review 2013.
Recent Results Cancer Res
; 202: 59-63, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24531778
13.
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?
BJU Int
; 112(5): 602-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23448270
14.
Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
Aging Male
; 16(1): 1-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23373674
15.
Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.
Can J Urol
; 20(3): 6756-60, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23783043
16.
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.
Eur Urol
; 84(5): 503-509, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088597
17.
Can the prostate risk calculator based on Western population be applied to Asian population?
Prostate
; 72(7): 721-9, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21837777
18.
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy.
Prostate
; 72(1): 108-15, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21538424
19.
Screening and prostate-cancer mortality in a randomized European study.
N Engl J Med
; 360(13): 1320-8, 2009 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19297566
20.
ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.
Mod Pathol
; 25(3): 471-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22080055